Axsome's phase III FOCUS study, evaluating solriamfetol for treating attention deficit hyperactivity disorder, meets its primary and key secondary...

Cassava stock crashes 32% as its investigational Alzheimer's disease drug fails to meet the prespecified co-primary endpoints in the second late-stage...

UNITY Biotechnology stock loses 29% as the mid-stage DME study of the lead candidate, UBX1325, fails to achieve statistical significance for the...

Egypt’s overall budget deficit narrowed slightly in the first six months of the fiscal year, while the primary surplus rose to about EGP 230bn, its...

Egypt’s overall budget deficit narrowed slightly in the first six months of the fiscal year, while the primary surplus rose to about EGP 230bn, its...

Despite the current downward trend of NVO, it is a good stock to add to one's portfolio for long-term gains due to strong demand for its GLP-1 drugs.

The New York Times is reporting that billionaire Elon Musk's Department of Government Efficiency is causing "chaos and confusion" at the National...

The New York Times is reporting that billionaire Elon Musk's Department of Government Efficiency is causing "chaos and confusion" at the National...

Special focus is also placed on products with high import value that are of strategic interest to Việt Nam’s key trading partners. To maintain...

BAVINA SOOKDEO As Trinidad and Tobago commemorates Spiritual Baptist Liberation Day on March 30, the legacy of resilience, faith, and perseverance is...